Abiopharma

New Form 6-K - Immuron Ltd Filed: 2025-09-02 AccNo: 0001213900-25-082922 Size: 4 MB

Revvity - Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina

Calidi Biotherapeutics - Calidi Biotherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

OmniAb - OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

Silence Therapeutics to Participate in September Investor Conferences

Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Johnson & Johnson Unveils Results from the VARIPURE Substudy of SECURE, a Real-World Study on VARIPULSE™ Platform, at 2025 European Society of Cardiology (ESC) Congress

electroCore to Participate at H.C. Wainwright Global Investment Conference

Lineage Cell Therapeutics to Present at September 2025 Investor Conferences

Kodiak Sciences to Participate in Upcoming Scientific Conferences Highlighting KSI-101 in Patients with Macular Edema Secondary to Inflammation (MESI)

OmniAb to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH NUPSALA LIMITED

New Form 6-K - DR REDDYS LABORATORIES LTD Filed: 2025-09-02 AccNo: 0001575872-25-000555 Size: 113 KB

Stereotaxis to Present at Upcoming Investor Conferences

New Form 8-K - Sharps Technology Inc. Filed: 2025-09-02 AccNo: 0001641172-25-026137 Size: 830 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits